Home › Epilepsy › Wisconsin › Milwaukee
Epilepsy clinical trials in Milwaukee, WI
3 studies for Epilepsy are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
RecruitingPhase 1/2
- Medical College of Wisconsin, Milwaukee
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
RecruitingPhase 3
- Advocate Aurora Research institute, St. Luke's Medical Center, Milwaukee
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- Medical College of Wisconsin, Milwaukee
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA19 studies
- Houston, TX16 studies
- New York City, NY13 studies
- Washington, DC12 studies
- Philadelphia, PA11 studies
- Cleveland, OH9 studies
- Phoenix, AZ9 studies
- Durham, NC8 studies
- Rochester, MN8 studies
- Birmingham, AL7 studies
- Mountain View, CA7 studies
- St. Louis, MO7 studies
Other studies in Milwaukee
- Breast Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Cancer (all types)22 studies
- Lung Cancer21 studies
- Multiple Myeloma21 studies
- Prostate Cancer20 studies
- Follicular Lymphoma19 studies
- Pancreatic Cancer18 studies
- Non-Hodgkin Lymphoma18 studies
- Ovarian Cancer17 studies
- Acute Myeloid Leukemia17 studies
- Burkitt Lymphoma16 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.